Oramed Pharmaceuticals Inc The Journey of Oral Insulin: The Oramed Story Transcript
All right. Welcome, everyone. I am Malvika, the moderator for today's conversation, thank you so much for joining us today for this nice session from across the globe.
This is the fifth episode of biotechnology series, an ongoing series of conversations with experts and leaders in the biotech industry.
Here, our guests share with us there thought [in] leadership, there insights from their experience so far, their views on how the industry has evolved over the last few years and their perspectives on emerging trends and upcoming challenges. The topics for today's conversation is the journey of oral insulin, the Oramed' story. And on the panel today, we have Mr. Nadav Kidron, the CEO of Oramed Pharmaceuticals and Dr. Prabuddha Kundu, who is the Managing Director and Co-Founder at Premas Biotech.
Before we invite the panelists, I would like the attendees to know that we will open the session for questions towards the end of the session, about 20 minutes. As many questions as possible during that next duration will be taken up. I request
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
